Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

poly (ADP-ribose) polymerase inhibitor

(PAH-lee (... RY-bose) puh-LIH-meh-rays in-HIH-bih-ter)

A substance that blocks an enzyme in cells called PARP. PARP helps repair DNA when it becomes damaged. DNA damage may be caused by many things, including exposure to UV light, radiation, certain anticancer drugs, or other substances in the environment. In cancer treatment, blocking PARP may help keep cancer cells from repairing their damaged DNA, causing them to die. Poly (ADP-ribose) polymerase inhibitors are a type of targeted therapy. Also called PARP inhibitor.

poly (ADP-ribose) polymerase inhibitor

Search NCI's Dictionary of Cancer Terms